Eton Pharmaceuticals Inc (ETON)
US Market

Eton Pharmaceuticals (ETON) Stock Price & Analysis


ETON Stock Chart & Stats

Day’s Range$0 - $0
52-Week Range$1.98 - $5.81
Previous Close$3.91
Average Volume (3M)462.54K
Market Cap
Enterprise Value$86.69M
Total Cash (Recent Filing)$21.57M
Total Debt (Recent Filing)$6.16M
Price to Earnings (P/E)-305.5
Nov 16, 2023
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.01
Shares Outstanding25,653,396
10 Day Avg. Volume191,417
30 Day Avg. Volume462,542
Standard Deviation0.16
Financial Highlights & Ratios
Price to Book (P/B)8.67
Price to Sales (P/S)8.51
Price to Cash Flow (P/CF)3.80
P/FCF Ratio3.80
Enterprise Value/Market CapN/A
Enterprise Value/Revenue2.99
Enterprise Value/Gross Profit6.05
Enterprise Value/Ebitda-98.85
Price Target Upside155.75% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering1



Risk Analysis

Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy

Product Insights

Sorry, No Data Available
There is no website visitor data available for this stock.



What was Eton Pharmaceuticals Inc’s price range in the past 12 months?
Eton Pharmaceuticals Inc lowest stock price was $1.98 and its highest was $5.81 in the past 12 months.
    What is Eton Pharmaceuticals Inc’s market cap?
    Currently, no data Available
    When is Eton Pharmaceuticals Inc’s upcoming earnings report date?
    Eton Pharmaceuticals Inc’s upcoming earnings report date is Nov 16, 2023 which is in 43 days.
      How were Eton Pharmaceuticals Inc’s earnings last quarter?
      Eton Pharmaceuticals Inc released its earnings results on Aug 10, 2023. The company reported $0.18 earnings per share for the quarter, beating the consensus estimate of -$0.09 by $0.27.
        Is Eton Pharmaceuticals Inc overvalued?
        According to Wall Street analysts Eton Pharmaceuticals Inc’s price is currently Undervalued. Get more investment ideas with TipRanks Premium
          Does Eton Pharmaceuticals Inc pay dividends?
          Eton Pharmaceuticals Inc does not currently pay dividends.
          What is Eton Pharmaceuticals Inc’s EPS estimate?
          Eton Pharmaceuticals Inc’s EPS estimate is -$0.1.
            How many shares outstanding does Eton Pharmaceuticals Inc have?
            Eton Pharmaceuticals Inc has 25,653,397 shares outstanding.
              What happened to Eton Pharmaceuticals Inc’s price movement after its last earnings report?
              Eton Pharmaceuticals Inc reported an EPS of $0.18 in its last earnings report, beating expectations of -$0.09. Following the earnings report the stock price went up 38.077%.
                Which hedge fund is a major shareholder of Eton Pharmaceuticals Inc?
                Currently, no hedge funds are holding shares in ETON


                Eton Pharmaceuticals Stock Smart Score

                The Eton Pharmaceuticals stock analysis is based on the TipRanks Smart Score which is derived from 8 unique data sets including Analyst recommendations, Crowd Wisdom, Hedge Fund Activity, Media Sentiment and multiple Technical stock factors. The Smart Score is a quantitative, data-driven rating system and does not include human intervention.
                Learn more about TipRanks Smart Score

                Company Description

                Eton Pharmaceuticals Inc

                Eton Pharmaceuticals, Inc. engages in the development and commercialization of prescription drug products. Its portfolio consists of injectable, oral liquid, ophthalmic products pipelines. The company was founded in April 2017 and is headquartered in Deer Park, IL.


                Top 5 ETFs holding ETON

                Market Value
                Smart Score
                Vanguard Total Stock Market ETF
                Up to five ETFs with an Outperform Smart Score that hold ETON. The ETFs are listed according to market value of ETON within the ETF

                Forecast EPS vs Actual EPS

                Similar Stocks
                Price & Change
                ESSA Pharma
                Citius Pharmaceuticals
                Kala Pharmaceuticals

                Popular Stocks

                What's Included in PREMIUM?
                Make informed decisions based on Top Analysts' activity
                Know what industry insiders are buying
                Get actionable alerts from top Wall Street Analysts
                Find out before anyone else which stock is going to shoot up
                Get powerful stock screeners & detailed portfolio analysis